TearLab

San Diego, United States Founded: 2003 • Age: 23 yrs Acquired By Accelmed
Developer of diagnostic tests for detecting hyperosmolarity
Request Access

About TearLab

TearLab is a company based in San Diego (United States) founded in 2003 was acquired by Accelmed in May 2020.. TearLab has completed 1 acquisition, including OcuHub. TearLab operates in a competitive market with competitors including Toku Eyes, Quantel Medical, Cassini, BioLight and Pr3vent, among others.

  • Headquarter San Diego, United States
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Tearlab Corp
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
    $22.66 M
    -9
    as on Dec 31, 2019
  • Net Profit
    $-5.42 M
    -141
    as on Dec 31, 2019
  • EBITDA
    $722 K
    -79
    as on Dec 31, 2019
  • Latest Funding Round
    $1.75 M (USD), Post-IPO

    Oct 08, 2015

  • Investors
    CRG

    & 1 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Accelmed

    (May 11, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of TearLab
Headcount 50-200
Employee Profiles 5
Board Members and Advisors 6
Employee Profiles
People
Michael Marquez
CFO
People
Benjamin Sullivan
Chief Scientific Officer
People
Michael Berg
VP, Regulatory
People
Nadeen Dagel
Quality Systems Manager

Unlock access to complete

Board Members and Advisors
people
Richard Lindstrom
Directors
people
Dylan Harmon
Director
people
Uri Geiger
Director
people
Dolev Rafaeli
Director

Unlock access to complete

Funding Insights of TearLab

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $1.8M
  • First Round

    (10 Sep 2009)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2015 Amount Post-IPO - TearLab Valuation

investors

Mar, 2015 Amount Debt – Conventional - TearLab Valuation

investors

CRG
Jul, 2011 Amount Post-IPO - TearLab Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in TearLab

TearLab has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CRG and Accelmed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
CRG is recognized as a premier healthcare investment partner.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by TearLab

TearLab has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OcuHub. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Cloud-based health information platform for payers and doctors
2014
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - TearLab

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tearlab Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of TearLab

TearLab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Toku Eyes, Quantel Medical, Cassini, BioLight and Pr3vent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
AI-powered retinal images are analyzed for early disease detection.
domain founded_year HQ Location
Ultrasound and laser devices for ophthalmology are manufactured and marketed.
domain founded_year HQ Location
Corneal diagnostic solutions for astigmatism and topography are offered.
domain founded_year HQ Location
Diagnostics and therapeutics for ophthalmology
domain founded_year HQ Location
AI-based platform for newborn ophthalmic condition screening is offered.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tearlab

Frequently Asked Questions about TearLab

When was TearLab founded?

TearLab was founded in 2003 and raised its 1st funding round 6 years after it was founded.

Where is TearLab located?

TearLab is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

Who is the current CEO of TearLab?

Seph Jensen is the current CEO of TearLab.

What is the annual revenue of TearLab?

Annual revenue of TearLab is $22.66M as on Dec 31, 2019.

What does TearLab do?

TearLab develops diagnostics for hyperosmolarty. The company offers the TearLab Osmolarity Test for revealing tear film osmolarity (a sign of dry eye disease) by testing for disease markers in tears. The test is done using its proprietary TearLab point-of-care instrument.

Who are the top competitors of TearLab?

TearLab's top competitors include Toku Eyes, BioLight and Pr3vent.

How many acquisitions has TearLab made?

TearLab has made 1 acquisition, including OcuHub.

Who are TearLab's investors?

TearLab has 2 investors. Key investors include CRG, and Accelmed.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available